Literature DB >> 25230670

Mangravite et al. reply.

Lara M Mangravite1, Barbara E Engelhardt2, Matthew Stephens3, Ronald M Krauss4.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25230670     DOI： 10.1038/nature13630

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  GATM locus does not replicate in rhabdomyolysis study.

Authors:  James S Floyd; Joshua C Bis; Jennifer A Brody; Susan R Heckbert; Kenneth Rice; Bruce M Psaty
Journal:  Nature       Date:  2014-09-18       Impact factor: 49.962

2.  Cerivastatin, genetic variants, and the risk of rhabdomyolysis.

Authors:  Kristin D Marciante; Jon P Durda; Susan R Heckbert; Thomas Lumley; Ken Rice; Barbara McKnight; Rheem A Totah; Bani Tamraz; Deanna L Kroetz; Hisayo Fukushima; Rüdiger Kaspera; Joshua C Bis; Nicole L Glazer; Guo Li; Thomas R Austin; Kent D Taylor; Jerome I Rotter; Cashell E Jaquish; Pui-Yan Kwok; Russell P Tracy; Bruce M Psaty
Journal:  Pharmacogenet Genomics       Date:  2011-05       Impact factor: 2.089

3.  Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

Authors:  David J Graham; Judy A Staffa; Deborah Shatin; Susan E Andrade; Stephanie D Schech; Lois La Grenade; Jerry H Gurwitz; K Arnold Chan; Michael J Goodman; Richard Platt
Journal:  JAMA       Date:  2004-11-22       Impact factor: 56.272

4.  GATM gene variants and statin myopathy risk.

Authors:  D F Carr; A Alfirevic; R Johnson; H Chinoy; T van Staa; M Pirmohamed
Journal:  Nature       Date:  2014-09-18       Impact factor: 49.962

5.  A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.

Authors:  Lara M Mangravite; Barbara E Engelhardt; Marisa W Medina; Joshua D Smith; Christopher D Brown; Daniel I Chasman; Brigham H Mecham; Bryan Howie; Heejung Shim; Devesh Naidoo; QiPing Feng; Mark J Rieder; Yii-Der I Chen; Jerome I Rotter; Paul M Ridker; Jemma C Hopewell; Sarah Parish; Jane Armitage; Rory Collins; Russell A Wilke; Deborah A Nickerson; Matthew Stephens; Ronald M Krauss
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962
  5 in total
  2 in total

1.  GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals.

Authors:  Jasmine A Luzum; Joseph P Kitzmiller; Paul J Isackson; Changxing Ma; Marisa W Medina; Anees M Dauki; Eduard B Mikulik; Heather M Ochs-Balcom; Georgirene D Vladutiu
Journal:  Cell Metab       Date:  2015-04-07       Impact factor: 27.287

Review 2.  Creatine as a Candidate to Prevent Statin Myopathy.

Authors:  Maurizio Balestrino; Enrico Adriano
Journal:  Biomolecules       Date:  2019-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.